Insider buying
~$2.06M750K sh @ $2.75
Traded May 30, 2025 · filed 5 days later
A major shareholder of Taysha Gene Therapies paid $2.06M out of pocket for Taysha Gene Therapies shares. Shares held went up 36% with this purchase.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Holdings as of Mar 31, 2025 (Q1 2025) · Filed May 15, 2025
2 tracked managers disclosed the same change for Q1 2025. From a 13F filed May 15, 2025 covering holdings at Mar 31, 2025 — a quarter-end snapshot, not a live trade.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell.
Increased
Compared with the manager's Q4 2024 13F
8,672,630
18,787,866
+116.6%
Share count drives classification; reported value also moves with price
0.40%
Within the filing's reported positions, not the manager's total assets
2
For Q1 2025
Insider buying
Traded May 30, 2025 · filed 5 days later
A major shareholder of Taysha Gene Therapies paid $2.06M out of pocket for Taysha Gene Therapies shares. Shares held went up 36% with this purchase.
Fund moves
From a 13F filed May 23, 2025 covering holdings at Mar 31, 2025 — a quarter-end snapshot, not a live trade.
Fund moves
From a 13F filed Feb 14, 2025 covering holdings at Dec 31, 2024 — a quarter-end snapshot, not a live trade.
Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.